Good recap on the state of affairs.
First time I've read the the full study in Neurology (https://n.neurology.org/content/neurology/92/16/e1912.full.pdf).
Slightly concerned about the 56 % of diarrhea in the high dose. Hopefully it doesn't impact the ability for long term use of the drug.
Ann: Neuren Corporate Presentation, October 2019, page-14
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.71 |
Change
-0.040(0.29%) |
Mkt cap ! $1.762B | |||
| Open | High | Low | Value | Volume |
| $13.85 | $14.08 | $13.46 | $3.738M | 273.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2184 | $13.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.72 | 87 | 3 |
View Market Depth
| Last trade - 13.20pm 10/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |